Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Mesna, sold under the brand name Mesnex among others, is a medication used in those taking cyclophosphamide or ifosfamide to decrease the risk of bleeding from the bladder. It is used either by mouth or injection into a vein.
Applications, Medical uses & Names
Explore the main themes, entities and connections around Mesna. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cyclophosphamide ifosfamide used administration metabolites chemotherapy medical name mouth urotoxic side effects include use acrolein pregnancy also reaction compounds iv
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Mesna | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Mesna | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Mesna | ATC code | R05CB05 (WHO) V03AF01 (WHO) | 1.00 | infobox |
| Mesna | Bioavailability | 45–79% (by mouth) | 1.00 | infobox |
| Mesna | CAS Number | 19767-45-4 N | 1.00 | infobox |
| Mesna | ChEMBL | ChEMBL975 Y | 1.00 | infobox |
| Mesna | ChemSpider | 27663 Y | 1.00 | infobox |
| Mesna | CompTox Dashboard (EPA) | DTXSID1020809 | 1.00 | infobox |
| Mesna | DrugBank | DB09110 Y | 1.00 | infobox |
| Mesna | ECHA InfoCard | 100.039.336 | 1.00 | infobox |
| Mesna | Elimination half-life | 0.36–8.3 hours | 1.00 | infobox |
| Mesna | Excretion | kidney | 1.00 | infobox |
| Mesna | Formula | C2H5NaO3S2 | 1.00 | infobox |
| Mesna | KEGG | D01459 Y | 1.00 | infobox |
| Mesna | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Mesna | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Mesna | Legal status | US: ℞-only | 1.00 | infobox |
| Mesna | Metabolism | Oxidised in circulation | 1.00 | infobox |
| Mesna | Molar mass | 164.17 g·mol−1 | 1.00 | infobox |
| Mesna | Pregnancy category | AU: B1 | 1.00 | infobox |
| Mesna | Pronunciation | /ˈmɛznə/ | 1.00 | infobox |
| Mesna | PubChem CID | 29769 | 1.00 | infobox |
| Mesna | Routes of administration | By mouth, intravenous | 1.00 | infobox |
| Mesna | UNII | NR7O1405Q9 | 1.00 | infobox |
| Mesna | is a | organosulfur compound | 0.90 | text |
| Mesna | is a | water-soluble compound with antioxidant properties | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.